Inari Medical Inc
NASDAQ:NARI
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
37.11
66.1
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one NARI stock under the Base Case scenario is 33.36 USD. Compared to the current market price of 49.66 USD, Inari Medical Inc is Overvalued by 33%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Inari Medical Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for NARI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Inari Medical Inc
Balance Sheet Decomposition
Inari Medical Inc
Current Assets | 263.4m |
Cash & Short-Term Investments | 111.5m |
Receivables | 84.4m |
Other Current Assets | 67.4m |
Non-Current Assets | 433.9m |
Long-Term Investments | 1.5m |
PP&E | 72.4m |
Intangibles | 357.2m |
Other Non-Current Assets | 2.8m |
Current Liabilities | 148.8m |
Accounts Payable | 15.5m |
Accrued Liabilities | 133.3m |
Non-Current Liabilities | 113.7m |
Other Non-Current Liabilities | 113.7m |
Earnings Waterfall
Inari Medical Inc
Revenue
|
574.5m
USD
|
Cost of Revenue
|
-75.7m
USD
|
Gross Profit
|
498.8m
USD
|
Operating Expenses
|
-546.7m
USD
|
Operating Income
|
-47.9m
USD
|
Other Expenses
|
-30.6m
USD
|
Net Income
|
-78.6m
USD
|
Free Cash Flow Analysis
Inari Medical Inc
USD | |
Free Cash Flow | USD |
Inari Medical reported third-quarter 2024 revenue of $153.4 million, a 21% increase year-over-year, driven by robust VTE and emerging therapies. International revenue surged 76.4% to $11.5 million. The company raised its full-year revenue guidance to between $601.5 million and $604.5 million, reflecting a growth of 22% to 22.5%. Inari anticipates reaching sustained operating profitability in the first half of 2025, with expected breakeven GAAP operating income in Q4. The upcoming PEERLESS data may unlock a $150 million market opportunity as the company continues to penetrate underdeveloped therapy markets internationally.
What is Earnings Call?
NARI Profitability Score
Profitability Due Diligence
Inari Medical Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.
Score
Inari Medical Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.
NARI Solvency Score
Solvency Due Diligence
Inari Medical Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Score
Inari Medical Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NARI Price Targets Summary
Inari Medical Inc
According to Wall Street analysts, the average 1-year price target for NARI is 65.86 USD with a low forecast of 48.48 USD and a high forecast of 90.3 USD.
Dividends
Current shareholder yield for NARI is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
NARI Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Inari Medical, Inc. operates as a medical device company. The company is headquartered in Irvine, California and currently employs 800 full-time employees. The company went IPO on 2020-05-22. The firm operates through the development and commercialization of invasive mechanical thrombectomy devices to treat thromboembolism in the venous system. Its product offerings consist of two minimally invasive, catheter-based mechanical thrombectomy systems, which are for venous system and the treatment of the two distinct manifestations of venous thromboembolism (VTE), deep vein thrombosis (DVT), and pulmonary embolism (PE). The Company’s products include ClotTriever System, FlowTriever System, FlowSaver, FlowStasis and FlowTriever 2. The ClotTriever system is a mechanical thrombectomy system designed to core, capture and remove large clots from large vessels and is used to treat DVT and its components include ClotTriever Catheter and ClotTriever Sheath. The FlowTriever is a large bore catheter-based aspiration and mechanical thrombectomy system designed to remove large clots from large vessels to treat PE.
Contact
IPO
Employees
Officers
The intrinsic value of one NARI stock under the Base Case scenario is 33.36 USD.
Compared to the current market price of 49.66 USD, Inari Medical Inc is Overvalued by 33%.